Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Sterilization, Female, Fallopian Tube Occlusion
Interventions: Hysterosalpingogram (HSG); Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Influenza
Interventions: Peramivir; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Up to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2012
U.S. locations: 29
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Orange, California + 25 more

Conditions: Enhanced Recovery Pathway, Endoscopy
Interventions: Ondansetron 4 MG, Lactated Ringers, Intravenous, Early Mobilization, Early PO Intake; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy Subjects
Interventions: GSK1349572 250 mg, Placebo Suspension, Moxifloxacin 400 mg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Osteosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
Interventions: sorafenib tosylate, therapeutic conventional surgery, laboratory biomarker analysis, pharmacological study, computed tomography, dynamic contrast-enhanced magnetic resonance imaging; Drug · Procedure · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
Interventions: citalopram hydrobromide, escitalopram oxalate, gabapentin, sertraline hydrochloride, tamoxifen citrate, venlafaxine, molecular genetic technique, high performance liquid chromatography, laboratory biomarker analysis, pharmacological study, adjuvant therapy; Drug · Genetic · Other + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 120 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 6
States / cities: Indianapolis, Indiana • Baltimore, Maryland • Ann Arbor, Michigan + 3 more

Conditions: Fluid Retention Tissue
Interventions: u-Cor System, ZOE Fluid Status Monitor; Device
Lead sponsor: Zoll Medical Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Lakewood, Colorado • Orlando, Florida • Minneapolis, Minnesota

Conditions: Hemodynamic Monitoring
Interventions: Starling; Device
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 1,207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 9
States / cities: Denver, Colorado • Quincy, Illinois • Kansas City, Kansas + 5 more

Conditions: Status Epilepticus
Interventions: propofol, thiopental/pentobarbital; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 16 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Infertility
Interventions: Vitrification via slush nitrogen; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Conditions: Postoperative Pain, Cesarean Section, Acetaminophen
Interventions: Acetaminophen, Placebos; Drug
Lead sponsor: Main Line Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Wynnewood, Pennsylvania

Conditions: Cocaine Use Disorder
Interventions: TMS to dmPFC, TMS to dlPFC, Sham iTBS; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Normal fluid intake without true lemon, Double fluid intake plus 3 bottles of water with True Lemon; Dietary Supplement
Lead sponsor: Adam Howe, MD; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Albany, New York

Conditions: SIRS, Balanced Fluids, Plasmalyte
Interventions: Not listed
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Deerfield, Illinois

Conditions: Urinary Stones
Interventions: Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer, Standard Ureteroscopic Laser Lithotripsy; Device
Lead sponsor: Avvio Medical; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 23
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 20 more

Conditions: Obesity; Familial, Pregnancy Related
Interventions: Very-low energy Diet (VLED), Standard of care (SOC); Dietary Supplement · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Metastatic Colorectal Cancer, Liver Metastases
Interventions: Dupilumab, Toripalimab; Drug
Lead sponsor: Dan Feng; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Cystic Fibrosis
Interventions: Inhaled Vancomycin, Placebo (Sterile Water), Rifampin, Trimethoprim/Sulfamethoxazole (TMP/SMX), Doxycycline, Mupirocin Intranasal Creme, 4% chlorhexidine gluconate liquid skin cleanser; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 12 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Cleveland, Ohio

Conditions: Perinatal Depression, Chronic Pain
Interventions: No intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Intervertebral Disc Disease, Intervertebral Disc Degeneration, Spondylosis, Spondylolisthesis, Spinal Stenosis
Interventions: NuCel with Autograft; Other
Lead sponsor: NuTech Medical, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Lipoproteins, Inflammatory Response
Interventions: Whole eggs, Egg yolks, Egg whites; Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Healthy Volunteers
Interventions: LY2452473; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Ovarian Failure, Perimenopausal Disorder, Hormone Disturbance
Interventions: lipoaspiration harvest tSVF, Platelet Rich Plasma, Endovaginal Ultrasound, Cellular Isolation cSVF, Normal Saline (NS) .9% 10 mL Injection, emulsification tSVF; Procedure · Device · Drug
Lead sponsor: Black Tie Medical, Inc.; Industry
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Colchester, Vermont

Conditions: Menopausal and Perimenopausal Disorder, Unspecified, Atrophic Vaginitis
Interventions: Vaginal Lubrication Ring for Vaginal Dryness; Device
Lead sponsor: J3 Bioscience, Inc.; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion

Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza

Enhanced Recovery Pathway for Endoscopy

Study to Assess Cardiac Conduction of GSK1349572

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Measuring Thoracic Impedance in Hemodialysis Patients With the u-Cor Monitoring System

Starling Registry Study

Treatment of Refractory Status Epilepticus

Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen

A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section

Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder

Variation in Urine Electrolytes, pH and Specific Gravity Throughout the Day

Effects of IV Chloride Content on Outcomes

Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH)

Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)

CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean

Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine

Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles

Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects

Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF

Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness